Growth Metrics

Humana (HUM) Current Deferred Revenue (2016 - 2025)

Humana has reported Current Deferred Revenue over the past 17 years, most recently at $356.0 million for Q4 2025.

  • Quarterly results put Current Deferred Revenue at $356.0 million for Q4 2025, up 36.92% from a year ago — trailing twelve months through Dec 2025 was $356.0 million (up 36.92% YoY), and the annual figure for FY2025 was $356.0 million, up 36.92%.
  • Current Deferred Revenue for Q4 2025 was $356.0 million at Humana, up from $265.0 million in the prior quarter.
  • Over the last five years, Current Deferred Revenue for HUM hit a ceiling of $7.5 billion in Q3 2023 and a floor of $195.0 million in Q3 2024.
  • Median Current Deferred Revenue over the past 5 years was $287.0 million (2022), compared with a mean of $1.6 billion.
  • Biggest five-year swings in Current Deferred Revenue: surged 2694.7% in 2023 and later crashed 97.41% in 2024.
  • Humana's Current Deferred Revenue stood at $254.0 million in 2021, then rose by 12.6% to $286.0 million in 2022, then decreased by 6.99% to $266.0 million in 2023, then dropped by 2.26% to $260.0 million in 2024, then soared by 36.92% to $356.0 million in 2025.
  • The last three reported values for Current Deferred Revenue were $356.0 million (Q4 2025), $265.0 million (Q3 2025), and $274.0 million (Q2 2025) per Business Quant data.